Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Head and Neck Cancer

  Free Subscription


Articles published in Am J Surg

Retrieve available abstracts of 50 articles:
HTML format



Single Articles


    March 2024
  1. INNES AM, van Galen P
    Insights from the hereditary endocrine clinic.
    Am J Surg. 2024;229:203-204.
    PubMed    


  2. HERRERA M, Hussein MH, Persons E, Alias MR, et al
    Survival benefits of extensive surgery in patients with papillary thyroid microcarcinoma.
    Am J Surg. 2024;229:99-105.
    PubMed     Abstract available


  3. TRAN A, Weigel RJ, Beck AC
    ATA risk stratification in papillary thyroid microcarcinoma has low positive predictive value when identifying recurrence.
    Am J Surg. 2024;229:106-110.
    PubMed     Abstract available


    February 2024
  4. SMITH ER, Frye CC, Pandian TK, Gillanders WE, et al
    Molecular characteristics of isthmus papillary thyroid cancers: Supporting evidence for unfavorable clinical behavior.
    Am J Surg. 2024;228:146-150.
    PubMed     Abstract available


  5. MONTGOMERY KB, Fazendin JM, Chen H, Broman KK, et al
    Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension.
    Am J Surg. 2024;228:173-179.
    PubMed     Abstract available


    August 2023
  6. KUO LE, Suh I
    Can we improve preoperative staging for thyroid cancer?
    Am J Surg. 2023;226:170.
    PubMed    


  7. K SAH R, Mayilvaganan S
    "Primary hyperparathyroidism after radioactive iodine therapy. Is it a distinct clinical entity?".
    Am J Surg. 2023;226:296.
    PubMed    


  8. SOEGAARD BALLESTER JM, Finn CB, Ginzberg SP, Kelz RR, et al
    Thyroid cancer pathologic upstaging: Frequency and related factors.
    Am J Surg. 2023;226:171-175.
    PubMed     Abstract available


    July 2023
  9. SANDILOS G, Lou J, Butchy MV, Gaughan JP, et al
    Features of mixed medullary thyroid tumors: An NCDB analysis of clinicopathologic characteristics and survival.
    Am J Surg. 2023;226:53-58.
    PubMed     Abstract available


    June 2023
  10. WATANABE A, Wiseman SM
    Quality indicators for thyroid cancer care: What should surgeons know?
    Am J Surg. 2023;225:1108-1110.
    PubMed    


  11. GOODSELL K, Ermer J, Amjad W, Swisher-McClure S, et al
    External beam radiotherapy for thyroid cancer: Patients, complications, and survival.
    Am J Surg. 2023;225:994-999.
    PubMed     Abstract available


    May 2023
  12. MASHAT A, Hilzenrat R, Masoudi H, Walker B, et al
    The influence of papillary features on the risk of malignancy in thyroid nodules diagnosed as atypia of undetermined significance or follicular lesion of undetermined significance.
    Am J Surg. 2023;225:857-860.
    PubMed     Abstract available


    March 2023
  13. ZHAO HH, Pickney C, Sarode AL, Kim-Mackow A, et al
    Varying impact of patient age on the rising rate of pediatric thyroid cancer: Analysis of NCDB database (2004-2017).
    Am J Surg. 2023;225:532-536.
    PubMed     Abstract available


    February 2023
  14. LUFF MK, Kim J, Tseng CH, Livhits MJ, et al
    Racial/ethnic disparities in thyroid cancer in California, 1999-2017.
    Am J Surg. 2023;225:298-303.
    PubMed     Abstract available


    January 2023
  15. BOBANGA I, Jin J, Wilhelm S, Sarode A, et al
    Primary hyperparathyroidism after radioactive iodine therapy: Is it a distinct clinical entity?
    Am J Surg. 2023;225:180-183.
    PubMed     Abstract available


    December 2022
  16. SWANSON J, Littau M, Tonelli C, Cohn T, et al
    A matched cohort comparison of endoscopic resection, chemoradiation and esophagectomy in the treatment of early-stage esophageal squamous cell carcinoma.
    Am J Surg. 2022 Dec 2:S0002-9610(22)00782-6. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available


    November 2022
  17. KITAJIMA T, Okugawa Y, Shimura T, Yamashita S, et al
    Combined assessment of muscle quality and quantity predicts oncological outcome in patients with esophageal cancer.
    Am J Surg. 2022 Nov 29:S0002-9610(22)00771-1. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available


    October 2022
  18. HSIAO V, Hanlon BM, Robbins SE, Connor NP, et al
    Discovering domains important to health-related quality of life in differentiated thyroid cancer.
    Am J Surg. 2022;224:1176-1178.
    PubMed    


    September 2022
  19. FUNG MMH, Lang BH
    A prospective study evaluating the use of low-dose intravenous sedation and analgesia during radiofrequency ablation of symptomatic, benign thyroid nodules.
    Am J Surg. 2022;224:928-931.
    PubMed     Abstract available


    August 2022
  20. HARVEY A
    Using what we already have: Optimizing information from ultrasound and fine needle aspiration biopsy for decision making in thyroid nodular disease.
    Am J Surg. 2022;224:652.
    PubMed    


  21. PAJAK C, Cadili L, Nabata K, Wiseman SM, et al
    (68)Ga-DOTATATE-PET shows promise for diagnosis of recurrent or persistent medullary thyroid cancer: A systematic review.
    Am J Surg. 2022;224:670-675.
    PubMed     Abstract available


  22. DICKEY MV, Nguyen A, Wiseman SM
    Cancer risk estimation using American College of Radiology Thyroid Imaging Reporting and Data System for cytologically indeterminate thyroid nodules.
    Am J Surg. 2022;224:653-656.
    PubMed     Abstract available


  23. SUJKA J, DuCoin CG
    Dr. Velanovich's contributions to understanding Barrett's Esophagus and its treatment.
    Am J Surg. 2022;224:821-822.
    PubMed    


    July 2022
  24. STEINL GK, Stewart LA, McManus C, Lee JA, et al
    Ethanol ablation for the treatment of benign thyroid nodules.
    Am J Surg. 2022;224.
    PubMed     Abstract available


  25. SUTTON W, Crepeau PK, Canner JK, Karzai S, et al
    Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.
    Am J Surg. 2022;224.
    PubMed     Abstract available


    April 2022
  26. TAKEDA E, Kimura J, Okabayashi T, Sui K, et al
    Clinicopathological features and surgical outcomes of pancreatic metastasis from thyroid cancer.
    Am J Surg. 2022 Apr 12. pii: S0002-9610(22)00237.
    PubMed     Abstract available


  27. ZMIJEWSKI P, Kuo LE
    Can less Be more in the treatment of cN1a papillary thyroid microcarcinoma?
    Am J Surg. 2022;223:633-634.
    PubMed    


  28. RAMONELL KM, Yip L
    The impact of race and ethnicity on thyroid nodules, malignancy risk, and surgical management.
    Am J Surg. 2022;223:615-616.
    PubMed    


  29. ZHENG H, Lai V, Lu J, Kang JK, et al
    Comparing the rate and extent of malignancy in surgically excised thyroid nodules across race and ethnicity.
    Am J Surg. 2022;223:617-623.
    PubMed     Abstract available


  30. RAMONELL KM, Rentas C, Buczek E, Porterfield J Jr, et al
    Mediastinal parathyroidectomy: Utilization of a multidisciplinary, robotic-assisted transthoracic approach in challenging cases.
    Am J Surg. 2022;223:681-685.
    PubMed     Abstract available


  31. MATSON J, Lwin TM, Bouvet M
    Rapid intraoperative perfusion assessment of parathyroid adenomas with ICG using a wide-field portable hand-held fluorescence imaging system.
    Am J Surg. 2022;223:686-693.
    PubMed     Abstract available


    February 2022
  32. REILLY J, Faridmoayer E, Lapkus M, Pastewski J, et al
    Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00091.
    PubMed    


  33. SHALABY M, Hadedeya D, Toraih EA, Razavi MA, et al
    Predictive factors of radioiodine therapy failure in Graves' Disease: A meta-analysis.
    Am J Surg. 2022;223:287-296.
    PubMed     Abstract available


    January 2022
  34. KELLEY S, Beck AC, Weigel RJ, Howe JR, et al
    Influence of endocrine multidisciplinary tumor board on patient management and treatment decision making.
    Am J Surg. 2022;223:76-80.
    PubMed     Abstract available


    December 2021
  35. REILLY J, Faridmoayer E, Lapkus M, Pastewski J, et al
    Vascular invasion predicts advanced tumor characteristics in papillary thyroid carcinoma.
    Am J Surg. 2021 Dec 9. pii: S0002-9610(21)00724.
    PubMed     Abstract available


    October 2021
  36. ARYANPOUR Z, Asban A, Boyd C, Herring B, et al
    A single institution experience with papillary thyroid cancer: Are outcomes better at comprehensive cancer centers?
    Am J Surg. 2021;222:802-805.
    PubMed     Abstract available


    September 2021
  37. RAMONELL KM, Fazendin J
    The complex and heterogeneous entity of double adenomas in primary hyperparathyroidism.
    Am J Surg. 2021;222:481-482.
    PubMed    


  38. GOODSELL KE, Ermer JP, Zaheer S, Kelz RR, et al
    Double adenoma as a cause of primary hyperparathyroidism: Asymmetric hyperplasia or a distinct pathologic entity?
    Am J Surg. 2021;222:483-489.
    PubMed     Abstract available


  39. LIMBERG J, Stefanova D, Thiesmeyer JW, Ullmann TM, et al
    Association of medicaid expansion of the Affordable Care Act with the stage at diagnosis and treatment of papillary thyroid cancer: A difference-in-differences analysis.
    Am J Surg. 2021;222:562-569.
    PubMed     Abstract available


    August 2021
  40. BACK K, Lee J, Choe JH, Kim JH, et al
    Total thyroidectomy can be overtreatment in cN1a papillary thyroid carcinoma patients whose tumor is smaller than 1 cm.
    Am J Surg. 2021 Aug 12. pii: S0002-9610(21)00474.
    PubMed     Abstract available


  41. SINCLAIR CF, Tellez MJ, Pelaez-Cruz R, Diaz-Baamonde A, et al
    Continuous neuromonitoring during radiofrequency ablation of benign thyroid nodules provides objective evidence of laryngeal nerve safety.
    Am J Surg. 2021;222:354-360.
    PubMed     Abstract available


    July 2021
  42. MCDOW AD, Roman BR, Saucke MC, Jensen CB, et al
    Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer.
    Am J Surg. 2021;222:111-118.
    PubMed     Abstract available


  43. MUSAVI LS, Fadavi D, He W, Sacks JM, et al
    Impact of payer status and hospital volume on outcomes after head and neck oncologic reconstruction.
    Am J Surg. 2021;222:173-178.
    PubMed     Abstract available


    June 2021
  44. SCHWEITZER CL, Wiseman SM
    Adoption of intraoperative nerve monitoring for thyroidectomy: Supported by real-world NSQIP data.
    Am J Surg. 2021;221:1285-1290.
    PubMed    


  45. WISEMAN SM, Saleh N, Tootooni A, Eshraghi P, et al
    Parathyroid identification during thyroid and parathyroid operations: A pilot study evaluating a novel low cost autofluorescence based device.
    Am J Surg. 2021;221:1150-1158.
    PubMed     Abstract available


    May 2021
  46. ESCE AR, Redemann JP, Sanchez AC, Olson GT, et al
    Predicting nodal metastases in papillary thyroid carcinoma using artificial intelligence.
    Am J Surg. 2021 May 13. pii: S0002-9610(21)00281.
    PubMed     Abstract available


  47. NYLEN C, Eriksson FB, Yang A, Aniss A, et al
    Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
    Am J Surg. 2021;221:886-892.
    PubMed     Abstract available


    April 2021
  48. WILSON M, Patel A, Goldner W, Baker J, et al
    Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
    Am J Surg. 2021;221:804-808.
    PubMed     Abstract available


    March 2021
  49. BORTZ MD, Khokar A, Winchester DJ, Moo-Young TA, et al
    Radioactive iodine-125 seed localization as an aid in reoperative neck surgery.
    Am J Surg. 2021;221:534-537.
    PubMed     Abstract available


  50. TAKEDA FR, Kodama Pertille Ramos MF, Pereira MA, Muniz RR, et al
    Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era.
    Am J Surg. 2021;221:631-636.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.